Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by ...

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Carl Roberts, Katie Owen and Nathan Blake chat with Wales players Lilly Woodham, Elise Hughes and Josie Green as they embark ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

David Lopez Lilly, Joshua Michael Stehle, and Crystal Aguilar slated to appear in court on Friday Trump’s endorsement helped ...

Decorator Amanda Reynal's "Lilly Pad" room pays homage to the late fashion icon Lilly Pulitzer at the 2025 Kips Bay Decorator ...

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

Former Tennessee football offensive lineman Trey Teague is sharing lessons learned in Knoxville with his daughter, Lilly, a ...

We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a ...

Lilly's retatrutide shows remarkable weight loss in trials but raises concerns with side effects possibly linked to the drug like nausea and kidney stones. Read more here.